Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Ethereum Foundation changes reflect strategic focus, not crisis, says Joe Lubin.

Market News
08 Jun 2026
Cointribune
View Source
Neutral
pluang ai news

Joe Lubin, Ethereum co-founder, denies any crisis at the Ethereum Foundation amid recent budget cuts and leadership changes. He explains these shifts are a strategic refocusing to keep the foundation dedicated to protocol and network neutrality, while other groups handle adoption and growth. Lubin highlights the importance of separating protocol management from commercial interests to maintain decentralization. He also sees new opportunities for Ethereum with AI integration and institutional adoption, suggesting the ecosystem remains strong despite criticism.

More News

McEwen's Grey Fox Project PFS shows 15-year mine life extension with strong returns and $181M CAPEX.

McEwen's Grey Fox Project PFS shows 15-year mine life extension with strong returns and $181M CAPEX.

McEwen Inc. announced a Pre-Feasibility Study (PFS) for its Grey Fox Project near Timmins, Ontario, projecting a 15-year mine life extension to 2041 and significant gold production growth at the Fox Complex. The project aims to increase annual gold o...

Company Fundamentals
Bullish
24 minutes ago
Heineken repurchases over 3.5 million shares in second tranche of €1.5B buyback program.

Heineken repurchases over 3.5 million shares in second tranche of €1.5B buyback program.

Heineken N.V. has repurchased a total of 3,535,760 shares under the second €750 million tranche of its €1.5 billion share buyback program as of June 5, 2026. The shares were bought both on the exchange and from Heineken Holding N.V., with an average ...

Company Fundamentals
Neutral
24 minutes ago
LYL273 trial shows reduced severe side effects with GI prophylaxis, expands to Phase 1/2 for metastatic colorectal cancer

LYL273 trial shows reduced severe side effects with GI prophylaxis, expands to Phase 1/2 for metastatic colorectal cancer

Lyell Immunopharma updated its Phase 1 trial of LYL273, a CAR T-cell therapy for relapsed or refractory metastatic colorectal cancer, showing gastrointestinal prophylaxis significantly reduced severe diarrhea and colitis from 55% to 10%. No severe cy...

Company Fundamentals
Bullish
24 minutes ago
Lixiang Education regains Nasdaq compliance with $5M minimum market value of publicly held shares.

Lixiang Education regains Nasdaq compliance with $5M minimum market value of publicly held shares.

Lixiang Education Holding Co., Ltd. announced it has regained compliance with Nasdaq's minimum market value of publicly held shares requirement, reaching at least $5 million for 10 consecutive business days from May 21 to June 4, 2026. This follows a...

Market News
Bullish
24 minutes ago
Credit Agricole Loire Haute-Loire publishes social shares prospectus approved by AMF

Credit Agricole Loire Haute-Loire publishes social shares prospectus approved by AMF

Credit Agricole Loire Haute-Loire has announced the publication of its social shares prospectus, approved by the French financial regulator AMF under approval number 26-181. The prospectus is available on the regional bank's website and provides deta...

Company Fundamentals
Neutral
26 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App